BidaskClub Downgrades Medidata Solutions (NASDAQ:MDSO) to Buy

BidaskClub cut shares of Medidata Solutions (NASDAQ:MDSO) from a strong-buy rating to a buy rating in a report issued on Saturday morning, BidAskClub reports.

A number of other brokerages have also issued reports on MDSO. William Blair lowered shares of Medidata Solutions from an outperform rating to a market perform rating in a research report on Wednesday, June 12th. TheStreet raised shares of Tupperware Brands from a d+ rating to a c rating in a research report on Friday, March 15th. Piper Jaffray Companies lowered shares of Medidata Solutions from an overweight rating to a neutral rating in a research report on Wednesday, June 12th. SunTrust Banks boosted their target price on shares of Camden Property Trust to $108.00 and gave the stock a buy rating in a research report on Thursday, June 13th. Finally, Guggenheim lowered shares of Medidata Solutions from a buy rating to a neutral rating and set a $92.25 target price on the stock. in a research report on Wednesday, June 12th. One research analyst has rated the stock with a sell rating, ten have given a hold rating and three have given a buy rating to the company. Medidata Solutions has an average rating of Hold and a consensus target price of $84.24.

NASDAQ:MDSO opened at $90.86 on Friday. Medidata Solutions has a 12 month low of $60.10 and a 12 month high of $98.60. The company has a market capitalization of $5.66 billion, a price-to-earnings ratio of 94.65, a price-to-earnings-growth ratio of 7.50 and a beta of 1.22. The company has a debt-to-equity ratio of 0.29, a quick ratio of 2.57 and a current ratio of 2.57. The company has a 50 day moving average price of $91.06.

Medidata Solutions (NASDAQ:MDSO) last released its quarterly earnings results on Tuesday, April 30th. The company reported $0.45 EPS for the quarter, beating the Zacks’ consensus estimate of $0.12 by $0.33. Medidata Solutions had a net margin of 7.99% and a return on equity of 9.28%. The company had revenue of $173.50 million for the quarter, compared to analyst estimates of $172.12 million. During the same quarter last year, the firm posted $0.40 earnings per share. The company’s quarterly revenue was up 16.3% compared to the same quarter last year. As a group, research analysts expect that Medidata Solutions will post 0.79 EPS for the current fiscal year.

In related news, Director Robert Taylor sold 3,294 shares of the business’s stock in a transaction on Thursday, June 6th. The shares were sold at an average price of $90.88, for a total transaction of $299,358.72. Following the transaction, the director now owns 41,757 shares of the company’s stock, valued at $3,794,876.16. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 4.70% of the company’s stock.

A number of institutional investors have recently made changes to their positions in MDSO. Norges Bank bought a new stake in Medidata Solutions in the 4th quarter valued at $46,802,000. Syquant Capital Sas bought a new stake in Medidata Solutions in the 2nd quarter valued at $31,293,000. BlackRock Inc. increased its holdings in Medidata Solutions by 4.3% in the 1st quarter. BlackRock Inc. now owns 7,293,413 shares of the company’s stock valued at $534,167,000 after buying an additional 297,812 shares during the period. Nikko Asset Management Americas Inc. increased its holdings in Medidata Solutions by 16.8% in the 1st quarter. Nikko Asset Management Americas Inc. now owns 1,259,943 shares of the company’s stock valued at $92,278,000 after buying an additional 181,553 shares during the period. Finally, ARK Investment Management LLC increased its holdings in Medidata Solutions by 19.4% in the 1st quarter. ARK Investment Management LLC now owns 1,117,845 shares of the company’s stock valued at $81,871,000 after buying an additional 181,286 shares during the period.

Medidata Solutions Company Profile

Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development and commercialization of new therapies. The company's platform solutions include data capture and management, and trial planning and management.

Read More: What is included in the gross domestic product?

Analyst Recommendations for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.